CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 78 filers reported holding CITIUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $234,286 | -43.0% | 342,324 | 0.0% | 0.00% | – |
| Q2 2023 | $410,789 | +568.3% | 342,324 | +551.6% | 0.00% | – |
| Q1 2023 | $61,465 | +48.1% | 52,534 | 0.0% | 0.00% | – |
| Q4 2022 | $41,502 | -35.2% | 52,534 | 0.0% | 0.00% | – |
| Q3 2022 | $64,000 | +33.3% | 52,534 | 0.0% | 0.00% | – |
| Q2 2022 | $48,000 | -92.9% | 52,534 | -86.2% | 0.00% | – |
| Q1 2022 | $679,000 | +21.5% | 379,314 | +4.5% | 0.00% | – |
| Q4 2021 | $559,000 | -22.8% | 363,101 | +1.7% | 0.00% | – |
| Q3 2021 | $724,000 | -37.4% | 356,921 | +7.4% | 0.00% | – |
| Q2 2021 | $1,157,000 | +1130.9% | 332,308 | +532.6% | 0.00% | – |
| Q1 2021 | $94,000 | – | 52,534 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | 498,783 | $394 | 0.05% |
| Inspire Advisors, LLC | 195,946 | $154,797 | 0.04% |
| Wealth Advisory Solutions, LLC | 155,850 | $123,122 | 0.03% |
| Miller Investment Management, LP | 50,000 | $39,500 | 0.01% |
| Virtu Financial LLC | 39,005 | $31 | 0.00% |
| Pasadena Private Wealth, LLC | 10,965 | $8,662 | 0.00% |
| Jump Financial, LLC | 49,251 | $38,908 | 0.00% |
| Csenge Advisory Group | 15,000 | $11,850 | 0.00% |
| Qube Research & Technologies Ltd | 120,580 | $95,258 | 0.00% |
| Syverson Strege & Co | 2,145 | $1,695 | 0.00% |